DeutschNewstral
Article
Bbarrons.com on 2021-03-20 00:51
Benefitfocus and Five Prime Therapeutics See Analyst Action
Related news
- BLeaf Group, Forma Therapeutics See Activist Actionbarrons.com
- BMetacrine, Prelude Therapeutics See Activist Actionbarrons.com
- BDecibel Therapeutics, Strategic Education See Activist Actionbarrons.com
- BBiotechs Mersana Therapeutics, Crinetics See Activist Actionbarrons.com
- BGlobal Indemnity, Werewolf Therapeutics See Activist Actionbarrons.com
- MFive Prime Therapeutics founder, CEO to step downmarketwatch.com
- BApartment Investment and Gemini Therapeutics See Activist Action2 min readbarrons.com
- BRain Therapeutics, Canadian National Railway See Activist Actionbarrons.com
- BGenesco, Immunocore See Activist Actionbarrons.com
- BRain Therapeutics and New York Times See Activist Action3 min readbarrons.com
- BAnaptysBio and Seagate Technology See Activist Actionbarrons.com
- BW.R. Grace and ThredUp See Activist Actionbarrons.com
- BOneSpan and LKQ See Activist Actionbarrons.com
- BEvolent Health and FireEye See Activist Actionbarrons.com
- BW.R. Grace, GameStop See Activist Actionbarrons.com
- BEnzo Biochem and Tenneco See Activist Actionbarrons.com
- BEnzo Biochem, Leaf Group See Activist Actionbarrons.com
- BAmazon Prime Day to See Strong Demand, but Headwinds Remain, Analyst Says2 min readbarrons.com
Prime Therapeutics CEO DuCharme to retirebizjournals.com- Prime Therapeutics promotes insider to CEO postbizjournals.com